Angiotensin converting enzyme inhibition modulates endogenous endothelin in chronic canine thoracic inferior vena caval constriction

Journal of Clinical Investigation

Volumn 97, Issue 5, 1996, Pages 1286-1292

  Clavell, Alfredo L ^a   Mattingly, Michael T ^a   Stevens, Tracy L ^a   Nir, Amiram ^a   Wright, R Scott ^a   Aarhus, Lawrence L ^a   Heublein, Dennise M ^a   Burnett Jr , John C ^a  

^a MAYO CLINIC   (United States)

Author keywords

converting enzyme inhibition; endothelin; receptor antagonism; systemic hemodynamics

Indexed keywords

2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; ALDOSTERONE; ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENDOTHELIN; RENIN;

ANIMAL MODEL; ARTICLE; CARDIOVASCULAR AUTOREGULATION; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOG; ENZYME INHIBITION; HEMODYNAMICS; INFERIOR CAVA VEIN; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTEMIC VASCULAR RESISTANCE;

EID: 0029978262     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118544     Document Type: Article

References (38)

1. Yanagisawa, M., H Kurihara, S. Kimura, Y. Tomobe, M. Kombayaski, Y Mitsui, Y. Yazaki, K. Goto, and T. Masaki. 1988. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (Lond.). 332: 411-415.
2. Ito, H., Y. Hirata, S. Adachi, M. Tanaka, M. Tsujino, A. Koike, A. Nogami, F. Marumo, and M. Hiroe. 1993. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J. Clin. Invest. 92:398-403.
3. Kohan, D.E. 1993. Endothelin production by human inner medullary collecting duct cells. J. Am. Soc. Nephrol 3:1719-1721.
4. Lerman, A., S.H Kubo, L.K. Tschumperlin, and J.C. Burnett, Jr. 1992. Plasma endothelin concentrations in humans with end-stage heart failure and after heart transplantation. J. Am. Coll. Cardiol. 20:849-853.
5. Saito, Y., K. Nakao, M. Mukoyama, and H. Imura. 1990. Increased plasma endothelin level in patients with essential hypertension (letter). N. Engl. J. Med. 322:205.
6. Lerman, A., B.S Edwards, J W. Hallet, D.M. Heublein, S.M. Sandberg, and J.C. Burnett. Jr. 1991. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N. Engl. J. Med. 325:997-1001.
7. Miyauchi, T., M. Yanagisawa, T. Tomizawa, Y. Sugishata, N. Suzuki, M. Fujino, P. Ajisaka, K. Goto, and T. Masaki. 1989. Increased plasma concentrations of endothelin-1 in acute myocardial infarction. Lancet. 2:53-54.
8. Masaki, T , S. Kimura, M. Yanagisawa, and K. Goto. 1991. Molecular and cellular mechanism of endothelin regulation: implications for vascular function. Circulation. 84:1457-1468
9. Nunez, D.J.R., M J. Brown, A P. Davenport, C.B. Neylon, J.P. Schofield, and R K. Wyse 1990. Endothelin-1 mRNA is widely expressed in porcine and human tissues. J. Clin. Invest. 85:1537-1541.
10. Arai, H., S. Hori, I Aramori, H Ohkubo, and S. Nakamishi. 1990. Cloning and expression of a cDNA encoding an endothelin receptor. Nature (Lond.). 348.732-735.
11. Sakurai, T., M. Yanagisawa, Y. Takuwa, H. Miyasaki, S. Kimura, K. Goto, and M. Masaki. 1990. Cloning of a cDNA encoding a non-isopeptide selective subtype of the endothelin receptor. Nature (Lond.). 348.732-735.
12. Cristol, J.P., T.D. Warner, C. Thiemermann, and J.R. Vane. 1993. Mediation via different receptors of the vasoconstrictor effects of endothelins and sarafotoxins in the systemic circulation and renal vasculature of the anesthetized rat. Br. J. Pharmacol. 108:776-779.
13. Pollock, D.M , and T.J. Opgenorth. 1993. Evidence for endothelin-induced renal vasoconstriction independent of ET-A receptor activation. Am. J. Physiol. 264:R222-R226.
14. B receptors in canine coronary arteries. Circ. Res. 74:105-114
15. Clozel, M , V. Breu, K. Burri, J.M. Cassal, W. Fischli, G.A. Gray, G. Hirth, B.M. Loeffler, M. Muller, W. Neidhart, and H. Ramuz 1993 Pathophysiologic role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature (Lond.). 365:759-761
16. Teerlink, J.R., B.M Loffler, P. Hess, J.P Maire, M. Clozel, and J.P. Clozel. 1994. Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47-0203 (Bosentan) Circulation 90:2510-2518.
17. Underwood, D., L. Aarhus, D. Heublein, and J.C. Burnett, Jr. 1992. Endothelin in thoracic inferior vena caval constriction. Am. J. Physiol 263:H951-H955.
18. Watkins, L., J A Burton, E. Haber, J.R. Cant, F.W. Smith, and A.C. Barger. 1976. The renin angiotensin aldosterone system in congestive failure in conscious dogs. J. Clin Invest 57:1606-1614.
19. Freeman, R H., J.O. Davis, and G.M. Williams. 1979. Effects of the oral converting enzyme inhibitor, SQ 14225, in a model of low cardiac output in dogs. Circ Res. 45:540-545.
20. Paganelli, W.C., J.R. Cant, R R. Pintal, I. Kifor, A.C. Barger, and V.J. Dzau. 1988. Plasma atrial natriuretic factor during chronic thoracic inferior vena caval constriction. Circ. Res. 62:279-285.
21. Aramori, I., H Nirei, M. Shoubo, K. Sogabe, K. Nakamura, H. Kojo, Y Notsu, T. Ono, and S. Nakanishi 1992 Subtype selectivity of a novel endothelin antagonist FR-139317 for the two endothelin receptors in transacted Chinese hamsters ovary cells. Mol. Pharmacol. 431:127-131.
22. Smith, H.W., N. Finkelstein, L. Aliminosa, B. Crawford, and M. Graber. 1945. The renal clearances of substituted hippuric acid derivatives and other aromatic acids in dogs and man. J. Clin. Invest. 42:388-404.
23. Burnett, J.C., Jr., P.C. Kao, D.C. Hu, D.W. Heser, D.M. Heublein, J.P. Granger, T.J. Opgenorth, and G S. Reeder. 1986. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science (Wash. DC). 231:1145-1147.
24. Haber, E., D. Loerner, K. Klemen, and A. Purnode. 1969. Application of a radioimmunoassay for angiotensin I to physiologic measurement of plasma renin activity in normal human subjects. J. Clin. Endocrinol. & Metab. 29:1349-1355.
25. Margulies, K.B., F L. Hildebrand, Jr , A. Lerman, M.A. Perrella and J.C. Burnett, Jr. 1990. Increased endothelin in experimental heart failure. Circulation. 82:2226 2230
26. Wei, C.M., A.L. Clavell, M. Yoshizumi, M.E. Lee, and J.C. Burnett, Jr 1994. Renal and cardiopulmonary endothelin-1 gene expression in experimental congestive heart failure. J. Am. Soc. Nephrol. 5:596a. (Abstr.)
27. Miller, W., M. Redfield, and J C. Burnett, Jr. 1989. Integrated cardiac, renal, and endocrine actions of endothelin. J. Clin. Invest. 83.3117-3120.
28. Garcia, N.H., and J.L. Garvin 1994. Endothelin biphasic effect on fluid absorption in the proximal straight tubule and its inhibitory cascade. J. Clin. Invest. 93:2572-2577.
29. Kohan, D.E., and E Padilla. 1993. Osmolar regulation of endothelin-1 production by rat inner medullary collecting duct. J. Clin Invest 91:1235-1240.
30. Kohno, M., K Yokokawa, T. Horio, K. Yasunari, K. Murakawa, and T Takeda. 1992. Atrial and brain natriuretic peptides inhibit the endothelin-1 secretory response to angiotensin II in porcine aorta. Circ. Res. 70.241-247.
31. Momose, N., K. Fukuo, S. Morimoto, and T. Ogihara 1993. Captopril inhibits endothelin-1 secretion from endothelial cells through bradykinin. Hypertension (Dallas). 21:921-924.
32. Boulanger, C., and T.F. Lüscher. 1990. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J. Clin Invest 85: 587-590.
33. Sandok, E.K , A. Lerman, A.J. Stingo, M.A. Perrella, P Gloviczki, and J.C. Burnett, Jr. 1992. Endothelin in a model of acute renal dysfunction: modulating action of atrial natriuretic factor. J. Am Soc. Nephrol. 3 196-202
34. Kourembanas, S., P.A. Marsden, L.P. McQuillan, and D V Faller 1991. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J. Clin. Invest 88:1054-1057
35. Stingo, A.J., A.L. Clavell, L.L. Aarhus, and J C. Burnett, Jr. 1993 Biological role for the endothelin-A receptor in aortic cross-clamping. Hypertension (Dallas) 22:62-66.
36. Nir, A., A.L. Clavell, D. Heublein, L.L. Aarhus, and J C. Burnett, Jr. 1994 Acute hypoxia and endogenous renal endothelin. J. Am Soc Nephrol 4:1920-1924.
37. Firth, J D., and P.J Ratcliffe 1992. Organ distribution of the three rat endothelin messenger RNAs and the effects of ischemia on renal gene expression. J. Clin. Invest. 90:1023-1031.
38. Clavell, A.L., A.J. Stingo, K.B Margulies, R.B. Brandt, and J.C. Burnett, Jr. 1995. Role of endothelin receptor subtypes in the in vivo regulation of renal function. Am. J. Physiol. 268:F455-F460.